Involvement of the stomach was more common with LPE (29%) than LGAL (7%) (P < 0.0001).
Results: Recurrence of the disease appeared in 32 cases (44%) and was more common with larger cysts.
Thigh pain (4.9%) was more common with cobalt-chrome femoral stems (6.5%) than titanium femoral stems (3.1%).
The only adverse events with an incidence that differed between groups were colonoscopy, diarrhea, and nausea; each was more common with ALN treatment (each P < 0.05).
Symptomatic hypoglycaemia was more common with glargine (p < 0.001).
However, type 2 diabetes was more common with obesity.
Overestimation of effectiveness was more common with syntactically ambiguous sentences than with the lexically ambiguous sentences.
TIMI major bleeding was more common with enoxaparin (3.7% vs 2.5% with UFH, P =.028).
Surgical intervention was more common with younger patients, female gender, private insurance, and larger hospital size.
Residual shunt was more common with Helex (22%) and CardioSEAL/STARFlex (40%) occluder devices than Amplatzer devices (9%; P =.005).
Angiographic restenosis also was more common with optimal PTCA than routine stenting (36.2% vs. 22.2%, p = 0.003).
